Clinical Trial: A Study to Assess the Bioavailability and Adhesion of Selegiline TDS in Healthy Subjects

U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT07571824) titled 'A Study to Assess the Bioavailability and Adhesion of Selegiline TDS in Healthy Subjects' on April 07.

Brief Summary: The purpose of this research study is to compare the bioavailability and adhesion of a generic Selegiline transdermal system (TDS) against the marketed comparator (EMSAM(R)) in healthy volunteers. Systemic and local safety and tolerability will be also observed and evaluated.

Study Start Date: March 23

Study Type: INTERVENTIONAL

Condition: Healthy Adult Participants

Intervention: DRUG: Selegiline TDS 6 mg/24 hours

Selegiline TDS 6 mg/24 hours

DRUG: EMSAM(R) TDS 6 mg/24 hours

EMSAM(R) TDS 6 mg/24 hours

Recruit...